AceBiome Signs Joint Research Agreement with Denmark's BactoLife
Collaboration to Discover New Microbiome-Based Materials
Biotechnology company Bioneer announced on January 26 that its subsidiary, AceBiome, has signed a joint development agreement (JDA) with Danish biotech company BactoLife.
BactoLife is a company specializing in protein-based gut health technology. It has previously attracted investments from Novo Holdings and the Bill & Melinda Gates Foundation, among others. The company is currently pursuing clinical trials and commercialization through a recent Series B funding round.
Under this agreement, the two companies will jointly conduct research on new functional ingredients focused on gut health. AceBiome will contribute its research achievements in probiotics, while BactoLife will provide its protein-binding technology. They plan to explore opportunities to enter the global health functional food market by discovering new materials.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A representative from AceBiome stated, "Through joint research with promising overseas biotech companies, we will assess the potential for developing next-generation health ingredients," adding, "We plan to expand our portfolio based on the microbiome."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.